Search - tctmd.com

Displaying 141 - 160 of 665

Sort: Relevancy | Date

Presentation TCT 2017

TCT 50: Impact of Anticoagulation Therapy on Valve Hemodynamic Deterioration Following Transcatheter Aortic Valve Replacement

Presenter: Peter C. Block, Lars Sondergaard, Maria Del Trigo, MD

October 31, 2017

Presentation TCT 2017

TCT 34: Prediction of Acute Kidney Injury After TAVR by New Biomarkers

Presenter: Reginald I. Low, Michael J. Rinaldi, Mani Arsalan, MD

October 31, 2017

Presentation TCT 2017

TCT 49: Long-Term Valve Function 5-9 Years After Transcatheter Aortic Valve Implantation: Data From the UK-TAVI Registry. On Behalf of the National Institute for Cardiovascular Outcomes Research (NICOR)

Presenter: Peter C. Block, Lars Sondergaard, Daniel J. Blackman

October 31, 2017

Presentation TCT 2017

TCT 33: Effect of Percutaneous Paravalvular Leak Closure on Hemolysis

Presenter: Reginald I. Low, Michael J. Rinaldi, Sidakpal Panaich, MD

October 31, 2017

Presentation TCT 2017

PARTNER 2A and SAPIEN 3 Cost-effectiveness: Cost-effectiveness of TAVR vs SAVR in Intermediate-Risk Patients With Aortic Stenosis

Presenter: Patrick W. Serruys, David J. Cohen

October 31, 2017

Presentation TCT 2017

Switzerland Presents: Cases Demonstrating TAVR Limitations

Presenter: Hyo-Soo Kim, Quang Ngoc Nguyen, Peter Wenaweser

October 31, 2017

Presentation TCT 2017

Switzerland Presents: A Case of Severe Symptomatic Aortic Stenosis and Complex Coronary Artery Disease - ECMO Support?

Presenter: Hyo-Soo Kim, Quang Ngoc Nguyen, Stephane Noble

October 31, 2017

Presentation TCT 2017

Canada Presents: Mitral, Tricuspid, and Aortic Valve Transcatheter Cases

Presenter: Hyo-Soo Kim, Quang Ngoc Nguyen, Anita Asgar

October 31, 2017

Presentation TCT 2017

Vietnam Presents: Challenging Cases of Mitral Valvuloplasty

Presenter: Hyo-Soo Kim, Quang Ngoc Nguyen

October 31, 2017

News Conference News TCT 2017

3-D Printing Opportunities Emerge for Cardiologists, Hospitals, and Device Companies Alike

Yael L. Maxwell

October 31, 2017

Presentation TCT 2017

Case #3 Conclusion: How We Managed This Patient

Presenter: Nick Curzen, Rod H. Stables

October 31, 2017

Presentation TCT 2017

Case Comments: How Should We Manage This Patient?

Presenter: Nick Curzen, Rod H. Stables, Roman Tarasov

October 31, 2017

Presentation TCT 2017

Minimally Invasive Transfemoral TAVR

Presenter: Francesco Saia, Gerhard C. Schuler, Francesco Burzotta

October 31, 2017

Presentation TCT 2017

Korea Presents: A Case of Valve-in-Valve TAVR

Presenter: Hyo-Soo Kim, Quang Ngoc Nguyen, Bon-Kwon Koo

October 31, 2017

Presentation TCT 2017

Case #3 Introduction: Patient With Previous CABG Undergoes Successful Transfemoral TAVR via a Tortuous Aorta; and a Few Hours Later, He Becomes Hypotensive, Complains of Chest Pain, and Has T-Wave Inversion in V1-V3

Presenter: Nick Curzen, Rod H. Stables

October 31, 2017

Presentation TCT 2017

Case Comments: What Does the Literature Tell Us?

Presenter: Nick Curzen, Rod H. Stables, Margaret B. McEntegart

October 31, 2017

Presentation TCT 2017

Case Comments: What Antithrombotic/Antiplatelet Regimen Should We Start?

Presenter: Nick Curzen, Rod H. Stables, Alexey Protopopov

October 31, 2017

Presentation TCT 2017

Case #2 Introduction: 85-Year-Old Patient With Previous Stents and Severe Aortic Stenosis, Reduced LVEF, Chronic Anemia, and Mild Renal Impairment Develops Atrial Fibrillation After TAVR

Presenter: Nick Curzen, Rod H. Stables

October 31, 2017

Presentation TCT 2017

Using Augmented and Virtual Reality in Aortic Valve Guidance Supports Accurate Valve Placement in TAVI

Presenter: Francesco Saia, Gerhard C. Schuler, Silvio J. Bezerra

October 31, 2017

Presentation TCT 2017

Case Comments: What Does the Literature Tell Us?

Presenter: Nick Curzen, Rod H. Stables, James R Wilkinson

October 31, 2017

Advertisement

TCT 50: Impact of Anticoagulation Therapy on Valve Hemodynamic Deterioration Following Transcatheter Aortic Valve Replacement

TCT 34: Prediction of Acute Kidney Injury After TAVR by New Biomarkers

TCT 49: Long-Term Valve Function 5-9 Years After Transcatheter Aortic Valve Implantation: Data From the UK-TAVI Registry. On Behalf of the National Institute for Cardiovascular Outcomes Research (NICOR)

TCT 33: Effect of Percutaneous Paravalvular Leak Closure on Hemolysis

PARTNER 2A and SAPIEN 3 Cost-effectiveness: Cost-effectiveness of TAVR vs SAVR in Intermediate-Risk Patients With Aortic Stenosis

Switzerland Presents: Cases Demonstrating TAVR Limitations

Switzerland Presents: A Case of Severe Symptomatic Aortic Stenosis and Complex Coronary Artery Disease - ECMO Support?

Canada Presents: Mitral, Tricuspid, and Aortic Valve Transcatheter Cases

Vietnam Presents: Challenging Cases of Mitral Valvuloplasty

3-D Printing Opportunities Emerge for Cardiologists, Hospitals, and Device Companies Alike

Case #3 Conclusion: How We Managed This Patient

Case Comments: How Should We Manage This Patient?

Minimally Invasive Transfemoral TAVR

Korea Presents: A Case of Valve-in-Valve TAVR

Case #3 Introduction: Patient With Previous CABG Undergoes Successful Transfemoral TAVR via a Tortuous Aorta; and a Few Hours Later, He Becomes Hypotensive, Complains of Chest Pain, and Has T-Wave Inversion in V1-V3

Case Comments: What Does the Literature Tell Us?

Case Comments: What Antithrombotic/Antiplatelet Regimen Should We Start?

Case #2 Introduction: 85-Year-Old Patient With Previous Stents and Severe Aortic Stenosis, Reduced LVEF, Chronic Anemia, and Mild Renal Impairment Develops Atrial Fibrillation After TAVR

Using Augmented and Virtual Reality in Aortic Valve Guidance Supports Accurate Valve Placement in TAVI

Case Comments: What Does the Literature Tell Us?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content